Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors
- PMID: 24151111
- PMCID: PMC4134680
- DOI: 10.1002/cncr.28437
Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors
Abstract
Background: Understanding the determinants of fatigue worsening may help distinguish between different fatigue phenotypes and inform clinical trial designs.
Methods: Patients with invasive cancer of the breast, prostate, colon/rectum, or lung were enrolled from multiple sites. At enrollment during an outpatient visit and 4 or 5 weeks later, patients rated their symptoms on a numerical rating scale from zero to 10. A 2-point change on that scale was considered clinically significant for a change in fatigue. Effects of demographic and clinical factors on patient-reported fatigue were examined using logistic regression models.
Results: In total, 3123 patients were enrolled at baseline, and 3032 patients could be analyzed for fatigue change. At baseline, 23% of patients had no fatigue, 35% had mild fatigue, 25% had moderate fatigue, and 17% had severe fatigue. Key parameters in a model of fatigue worsening included fatigue at baseline (odds ratio [OR], 0.75), disease status (OR, 1.99), performance status (OR, 1.38), history of depression (OR, 1.28), patient perception of bother because of comorbidity (OR, 1.26), and treatment exposures, including recent cancer treatment (OR, 1.77) and receipt of corticosteroids (OR, 1.37). The impact of sex was examined only in patients with colorectal and lung cancer, and it was a significant factor, with men most likely to experience worsening of fatigue (OR, 1.46).
Conclusions: Predictors of fatigue worsening included multiple factors that were difficult to modify, including the baseline fatigue level, sex, disease status, performance status, recent cancer treatment, bother because of comorbidity, and history of depression. Future fatigue prevention and treatment trial designs should account for key predictors of worsening fatigue.
Keywords: ambulatory care; cancer fatigue; medical oncology; symptom management.
© 2013 American Cancer Society.
Conflict of interest statement
Figures
Similar articles
-
Determinants of pain severity changes in ambulatory patients with cancer: an analysis from Eastern Cooperative Oncology Group trial E2Z02.J Clin Oncol. 2014 Feb 1;32(4):312-9. doi: 10.1200/JCO.2013.50.6071. Epub 2013 Dec 23. J Clin Oncol. 2014. PMID: 24366929 Free PMC article. Clinical Trial.
-
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0. Trials. 2021. PMID: 33810796 Free PMC article.
-
Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the Edmonton Symptom Assessment System.Support Care Cancer. 2012 May;20(5):1037-42. doi: 10.1007/s00520-011-1179-8. Epub 2011 May 4. Support Care Cancer. 2012. PMID: 21538097
-
Telephone interventions for symptom management in adults with cancer.Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2. Cochrane Database Syst Rev. 2020. PMID: 32483832 Free PMC article.
-
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. Health Technol Assess. 2020. PMID: 32975190 Free PMC article.
Cited by
-
Cancer-related and treatment-related fatigue.Gynecol Oncol. 2015 Mar;136(3):446-52. doi: 10.1016/j.ygyno.2014.10.013. Epub 2014 Oct 23. Gynecol Oncol. 2015. PMID: 25458588 Free PMC article. Review.
-
Inflammatory pathway genes associated with inter-individual variability in the trajectories of morning and evening fatigue in patients receiving chemotherapy.Cytokine. 2017 Mar;91:187-210. doi: 10.1016/j.cyto.2016.12.023. Epub 2017 Jan 19. Cytokine. 2017. PMID: 28110208 Free PMC article.
-
Testing a biobehavioral model of fatigue before adjuvant therapy in women with breast cancer.Cancer. 2019 Feb 15;125(4):633-641. doi: 10.1002/cncr.31827. Epub 2018 Dec 18. Cancer. 2019. PMID: 30561795 Free PMC article.
-
Predictors of fatigue in cancer patients: a longitudinal study.Support Care Cancer. 2019 Sep;27(9):3463-3471. doi: 10.1007/s00520-019-4660-4. Epub 2019 Jan 24. Support Care Cancer. 2019. PMID: 30680616
-
The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity.JACC CardioOncol. 2019 Sep;1(1):105-113. doi: 10.1016/j.jaccao.2019.08.007. Epub 2019 Sep 24. JACC CardioOncol. 2019. PMID: 32529192 Free PMC article.
References
-
- Donovan KA, McGinty HL, Jacobsen PB. A systematic review of research using the diagnostic criteria for cancer-related fatigue. Psycho-oncology. 2012 - PubMed
-
- Berger AM, Gerber LH, Mayer DK. Cancer-related fatigue: implications for breast cancer survivors. Cancer. 2012;118:2261–2269. - PubMed
-
- Campos MP, Hassan BJ, Riechelmann R, Del Giglio A. Cancer-related fatigue: a practical review. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2011;22:1273–1279. - PubMed
-
- Mitchell SA. Cancer-related fatigue: state of the science. PM & R. 2010;2:364–383. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical